Articles
Page 5 of 27
-
Citation: Molecular Neurodegeneration 2022 17:36
-
Circadian clocks, cognition, and Alzheimer’s disease: synaptic mechanisms, signaling effectors, and chronotherapeutics
Modulation of basic biochemical and physiological processes by the circadian timing system is now recognized as a fundamental feature of all mammalian organ systems. Within the central nervous system, these cl...
Citation: Molecular Neurodegeneration 2022 17:35 -
Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
The dietary consumption of cuprizone – a copper chelator – has long been known to induce demyelination of specific brain structures and is widely used as model of multiple sclerosis. Despite the extensive use ...
Citation: Molecular Neurodegeneration 2022 17:34 -
BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia
The BIN1 locus contains the second-most significant genetic risk factor for late-onset Alzheimer’s disease. BIN1 undergoes alternate splicing to generate tissue- and cell-type-specific BIN1 isoforms, which regula...
Citation: Molecular Neurodegeneration 2022 17:33 -
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
Genetic variation at the PTK2B locus encoding the protein Pyk2 influences Alzheimer’s disease risk. Neurons express Pyk2 and the protein is required for Amyloid-β (Aβ) peptide driven deficits of synaptic function...
Citation: Molecular Neurodegeneration 2022 17:32 -
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Alzheimer’s disease (AD) is the leading cause of dementia, clinically characterized by memory deficits and progressive cognitive decline. Despite decades of research effective therapies are lacking, and a larg...
Citation: Molecular Neurodegeneration 2022 17:31 -
VCP suppresses proteopathic seeding in neurons
Neuronal uptake and subsequent spread of proteopathic seeds, such as αS (alpha-synuclein), Tau, and TDP-43, contribute to neurodegeneration. The cellular machinery participating in this process is poorly under...
Citation: Molecular Neurodegeneration 2022 17:30 -
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
Synapse degeneration is an early event in pathological frontotemporal lobar degeneration (FTLD). Consequently, a surrogate marker of synapse loss could be used to monitor early pathologic changes in patients w...
Citation: Molecular Neurodegeneration 2022 17:29 -
Tauopathies: new perspectives and challenges
Tauopathies are a class of neurodegenerative disorders characterized by neuronal and/or glial tau-positive inclusions.
Citation: Molecular Neurodegeneration 2022 17:28 -
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer’s disease (AD) and is considered to result from neurodegeneration. T-tau levels, however, can be increased in very ...
Citation: Molecular Neurodegeneration 2022 17:27 -
Culture shock: microglial heterogeneity, activation, and disrupted single-cell microglial networks in vitro
Microglia, the resident immune cells of the brain, play a critical role in numerous diseases, but are a minority cell type and difficult to genetically manipulate in vivo with viral vectors and other approache...
Citation: Molecular Neurodegeneration 2022 17:26 -
Cellular stress signaling and the unfolded protein response in retinal degeneration: mechanisms and therapeutic implications
The retina, as part of the central nervous system (CNS) with limited capacity for self-reparation and regeneration in mammals, is under cumulative environmental stress due to high-energy demands and rapid prot...
Citation: Molecular Neurodegeneration 2022 17:25 -
In Memoriam of John T. Trojanowski, MD, PhD 1946-2022
Citation: Molecular Neurodegeneration 2022 17:24 -
Solving neurodegeneration: common mechanisms and strategies for new treatments
Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address...
Citation: Molecular Neurodegeneration 2022 17:23 -
The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD
Neuroinflammation is an important hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). An inflammatory reaction to neuronal injury is deemed vital for neuronal health a...
Citation: Molecular Neurodegeneration 2022 17:22 -
Does proteopathic tau propagate trans-synaptically in the brain?
Citation: Molecular Neurodegeneration 2022 17:21 -
The route of SARS-CoV-2 to brain infection: have we been barking up the wrong tree?
This letter draws attention to recent work supporting the notion that the SARS-CoV-2 virus may use the nervus terminalis rather than the olfactory nerve as a shortcut route from the nasal cavity to infect the ...
Citation: Molecular Neurodegeneration 2022 17:20 -
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
The implication of gut microbiota in the control of brain functions in health and disease is a novel, currently emerging concept. Accumulating data suggest that the gut microbiota exert its action at least in ...
Citation: Molecular Neurodegeneration 2022 17:19 -
Alzheimer’s disease – the journey of a healthy brain into organ failure
As the most common dementia, Alzheimer’s disease (AD) exacts an immense personal, societal, and economic toll. AD was first described at the neuropathological level in the early 1900s. Today, we have mechanist...
Citation: Molecular Neurodegeneration 2022 17:18 -
Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application
Alzheimer’s disease (AD) is the most common form of dementia, characterized by progressive cognitive impairment and neurodegeneration. Extensive clinical and genomic studies have revealed biomarkers, risk fact...
Citation: Molecular Neurodegeneration 2022 17:17 -
Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
Epidemiological studies suggest a link between the melanoma-related pigmentation gene melanocortin 1 receptor (MC1R) and risk of Parkinson’s disease (PD). We previously showed that MC1R signaling can facilitate n...
Citation: Molecular Neurodegeneration 2022 17:16 -
Differential regulation of progranulin derived granulin peptides
Haploinsufficiency of progranulin (PGRN) is a leading cause of frontotemporal lobar degeneration (FTLD). PGRN is comprised of 7.5 granulin repeats and is processed into individual granulin peptides in the lyso...
Citation: Molecular Neurodegeneration 2022 17:15 -
Retraction Note: Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13024-021-00438-3.
Citation: Molecular Neurodegeneration 2022 17:14 -
Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis
One of the key pathological hallmarks of Alzheimer disease (AD) is the accumulation of the amyloid-β (Aβ) peptide into amyloid plaques. The apolipoprotein E (APOE) gene is the strongest genetic risk factor for la...
Citation: Molecular Neurodegeneration 2022 17:13 -
Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease
The pathologic accumulation and aggregation of tau is a hallmark of tauopathies including Alzheimer’s disease (AD). However, the molecular mechanisms mediating tau aggregation in AD remain elusive. The inciden...
Citation: Molecular Neurodegeneration 2022 17:12 -
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in which many processes are detected including (neuro)inflammation. Many drugs have been tested for ALS in clinical trials but mos...
Citation: Molecular Neurodegeneration 2022 17:11 -
Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains
The role of viral infection in Alzheimer Disease (AD) pathogenesis is an area of great interest in recent years. Several studies have suggested an association between the human roseoloviruses, HHV-6 and HHV-7,...
Citation: Molecular Neurodegeneration 2022 17:10 -
Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
Loss of brain capillary pericyte is involved in the pathologies and cognitive deficits in Alzheimer’s disease (AD). The role of pericyte in early stage of AD pathogenesis remains unclear.
Citation: Molecular Neurodegeneration 2022 17:9 -
Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells
Spinal cord motor neurons (MNs) from human iPS cells (iPSCs) have wide applications in disease modeling and therapeutic development for amyotrophic lateral sclerosis (ALS) and other MN-associated neurodegenera...
Citation: Molecular Neurodegeneration 2022 17:8 -
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Leucine rich repeat kinase 2 (LRRK2) and SNCA are genetically linked to late-onset Parkinson’s disease (PD). Aggregated α-synuclein pathologically defines PD. Recent studies identified elevated LRRK2 expression i...
Citation: Molecular Neurodegeneration 2022 17:7 -
A novel H129-based anterograde monosynaptic tracer exhibits features of strong labeling intensity, high tracing efficiency, and reduced retrograde labeling
Viral tracers are important tools for mapping brain connectomes. The feature of predominant anterograde transneuronal transmission offers herpes simplex virus-1 (HSV-1) strain H129 (HSV1-H129) as a promising c...
Citation: Molecular Neurodegeneration 2022 17:6 -
The landscape of human tissue and cell type specific expression and co-regulation of senescence genes
Cellular senescence is a complex stress response that impacts cellular function and organismal health. Multiple developmental and environmental factors, such as intrinsic cellular cues, radiation, oxidative st...
Citation: Molecular Neurodegeneration 2022 17:5 -
The role of inflammasomes in vascular cognitive impairment
There is an increasing prevalence of Vascular Cognitive Impairment (VCI) worldwide, and several studies have suggested that Chronic Cerebral Hypoperfusion (CCH) plays a critical role in disease onset and progr...
Citation: Molecular Neurodegeneration 2022 17:4 -
Challenge accepted: uncovering the role of rare genetic variants in Alzheimer’s disease
The search for rare variants in Alzheimer’s disease (AD) is usually deemed a high-risk - high-reward situation. The challenges associated with this endeavor are real. Still, the application of genome-wide tech...
Citation: Molecular Neurodegeneration 2022 17:3 -
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
The use of animals as models of human physiology is, and has been for many years, an indispensable tool for understanding the mechanisms of human disease. In Parkinson’s disease, various mouse models form the ...
Citation: Molecular Neurodegeneration 2022 17:2 -
Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
In response to injury, neurons activate a program of organized axon self-destruction initiated by the NAD+ hydrolase, SARM1. In healthy neurons SARM1 is autoinhibited, but single amino acid changes can abolish au...
Citation: Molecular Neurodegeneration 2022 17:1 -
TDP-43 Pathology in Alzheimer’s Disease
Transactive response DNA binding protein of 43 kDa (TDP-43) is an intranuclear protein encoded by the TARDBP gene that is involved in RNA splicing, trafficking, stabilization, and thus, the regulation of gene exp...
Citation: Molecular Neurodegeneration 2021 16:84 -
Neuropathology and molecular diagnosis of Synucleinopathies
Synucleinopathies are clinically and pathologically heterogeneous disorders characterized by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies, Lewy neurites, neuronal cytopl...
Citation: Molecular Neurodegeneration 2021 16:83 -
Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories
Detection of the pathological and disease-associated alpha-synuclein (αSynD) in the brain is required to formulate the definitive diagnosis of multiple system atrophy (MSA) and Parkinson’s disease (PD). We recent...
Citation: Molecular Neurodegeneration 2021 16:82 -
Basal lamina changes in neurodegenerative disorders
Neurodegenerative disorders are a group of age-associated diseases characterized by progressive degeneration of the structure and function of the CNS. Two key pathological features of these disorders are blood...
Citation: Molecular Neurodegeneration 2021 16:81 -
MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
MicroRNA (miRNA) expression in the brain is altered in neurodegenerative diseases. Recent studies demonstrated that selected miRNAs conventionally regulating gene expression at the post-transcriptional level c...
Citation: Molecular Neurodegeneration 2021 16:80 -
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study
A detailed understanding of the pathological processes involved in genetic frontotemporal dementia is critical in order to provide the patients with an optimal future treatment. Protein levels in CSF have the ...
Citation: Molecular Neurodegeneration 2021 16:79 -
CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
Neurocognitive impairment is present in 50% of HIV-infected individuals and is often associated with Alzheimer’s Disease (AD)-like brain pathologies, including increased amyloid-beta (Aβ) and Tau hyperphosphor...
Citation: Molecular Neurodegeneration 2021 16:78 -
Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans
Parkinson’s disease is a disabling neurodegenerative movement disorder characterized by dopaminergic neuron loss induced by α-synuclein oligomers. There is an urgent need for disease-modifying therapies for Pa...
Citation: Molecular Neurodegeneration 2021 16:77 -
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as alternatives to classical monotarget therapies and microRNAs are of particular interest in that regard. MicroRNA resear...
Citation: Molecular Neurodegeneration 2021 16:76 -
Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain
Mitochondrial dysfunction is a feature of neurodegenerative diseases, including Alzheimer’s disease (AD). Changes in the mitochondrial DNA copy number (mtDNAcn) and increased mitochondrial DNA mutation burden ...
Citation: Molecular Neurodegeneration 2021 16:75 -
Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA
Citation: Molecular Neurodegeneration 2021 16:74 -
Synaptic dysfunction of Aldh1a1 neurons in the ventral tegmental area causes impulsive behaviors
Aldh1a1 neurons are a subtype of gamma-aminobutyric acid (GABA) inhibitory neurons that use Aldh1a1 rather than glutamate decarboxylase (GAD) as an enzyme for synthesizing GABA transmitters. However, the behav...
Citation: Molecular Neurodegeneration 2021 16:73 -
Correction to: Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Citation: Molecular Neurodegeneration 2021 16:72 -
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Oxidative stress (OS) is an imbalance between oxidant and antioxidant species and, together with other numerous pathological mechanisms, leads to the degeneration and death of motor neurons (MNs) in amyotrophi...
Citation: Molecular Neurodegeneration 2021 16:71
Follow
- ISSN: 1750-1326 (electronic)